logo
  

Starboard Announces Eight Director Candidates For Corteva Board - Quick Facts

Starboard Value LP has delivered a letter to Gregory Page, Chairman of the Board of Directors of Corteva, Inc. (CTVA) reiterating its belief that Corteva's operating performance dramatically understates the intrinsic value of the company's assets. Starboard Value LP, one of the largest shareholders of Corteva, has nominated a slate of eight director candidates for election at the company's 2021 Annual Meeting. The director nominees are: Jacques Croisetière; Lisa Crutchfield; David Everitt; James Gallogly; Janet Giesselman; Kerry Preete; Susan Schnabel; and Jeffrey Smith.

Starboard said the Board's reluctance to seriously consider leadership change is highly concerning.

"We have identified an industry expert with a superb track record of success and excellence who is willing and able to lead Corteva immediately. The Board's refusal to even speak with the individual we have identified is inexplicable," Starboard Value stated.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Mallinckrodt plc announced Wednesday that the U.S. Food and Drug Administration or FDA has approved StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen - dsat) for the treatment of adult patients with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated. Worldwide 5G mobile subscriptions are estimated to exceed 580 million by the end of 2021, according to the Ericsson Mobility Report. With subscriptions increasing at a rate of about a million per day, 5G remains on track to become the fastest adopted mobile generation in history. The growth in subscriptions is being lead by China, North America and the Gulf Cooperation Council markets. Elanco Animal Health Inc. (ELAN) and veterinary biopharmaceutical company Kindred Biosciences, Inc. (KIN) announced Wednesday they have entered into a definitive agreement for Elanco to acquire Kindred for $9.25 per share, or approximately $440 million. The acquisition further accelerates Elanco's...
Follow RTT